Abcam Sustainability Profile
Abcam plc, commonly known as Abcam, is a leading life sciences company headquartered in Cambridge, GB. Founded in 1998, Abcam has established itself as a prominent player in the biotechnology industry, specialising in the production and distribution of high-quality antibodies and related products. With a strong focus on research and development, the company serves a global market, with significant operations across Europe, North America, and Asia. Abcam's core offerings include a vast range of antibodies, proteins, and assays, which are renowned for their specificity and reliability. The company’s commitment to innovation and quality has positioned it as a trusted partner for researchers in academia and industry alike. Notable achievements include a robust portfolio of over one million products, making Abcam a go-to resource for scientists seeking advanced tools for their research.
DitchCarbon Score
How does Abcam's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abcam's score of 55 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abcam's reported carbon emissions
In 2022, Abcam's carbon emissions in Great Britain totalled approximately 659,000 kg CO2e, comprising 289,000 kg CO2e from Scope 1 and 370,000 kg CO2e from Scope 2. This represents a reduction from 2021, when emissions were about 1,272,000 kg CO2e (494,000 kg CO2e from Scope 1 and 778,000 kg CO2e from Scope 2). Globally, Abcam reported total emissions of about 102,263,000 kg CO2e in 2022, with Scope 1 emissions at 1,224,000 kg CO2e, Scope 2 at 3,370,000 kg CO2e, and a significant contribution from Scope 3 emissions at approximately 97,669,000 kg CO2e. This data is cascaded from the parent company, Danaher Corporation, reflecting their broader corporate climate commitments. Despite the substantial emissions figures, Abcam has not disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of defined reduction targets indicates a need for further commitment to climate action within the industry context.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 1,554,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,198,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 4,752,000 | 00,000,000 | 00,000,000 |
How Carbon Intensive is Abcam's Industry?
How Carbon Intensive is Abcam's Location?
Abcam's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abcam has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
